longbridge

The Nasdaq Biotechnology Index fell by 2%. Among the constituent stocks, Jyong Biotech dropped by 20.95%, BridgeBio Pharma fell by 15.21%, Sionna Therapeutics decreased by 15.12%, Abcellera Biologics declined by 14.98%, and Editas Medicine fell by 14.62%. Gilead Sciences rose by 2.15%, Silence Therapeutics increased by 5.12%, Erasca went up by 5.69%, and Phibro Animal Health surged by 22.02%

Wallstreetcn

The Nasdaq Biotechnology Index fell by 2%, with component stock Jyong Biotech down 20.95%, BridgeBio Pharma down 15.21%, Sionna Therapeutics down 15.12%, Abcellera Biologics down 14.98%, and Editas Medicine down 14.62%. Gilead Sciences, on the other hand, rose by 2.15%, with Silence Therapeutics up 5.12%, Erasca up 5.69%, and Phibro Animal Health up 22.02%

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

© 2026 Longbridge｜Terms of ServicePrivacy Policy